Management of INR 1.5 on Warfarin
For a patient with INR 1.5 while on warfarin, maintain the current warfarin dose without adjustment and recheck the INR in 1–2 weeks. 1
Rationale for No Dose Change
A single INR that is ≤0.5 units below the therapeutic target (e.g., INR 1.5–1.9 when goal is 2.0–3.0) should not trigger a dose increase; the American College of Chest Physicians recommends maintaining the current dose and rechecking in 1–2 weeks. 1
Evidence from randomized trials demonstrates that single-dose adjustments for slightly low INRs do not improve control: 44% of patients remained out of range after a dose change versus 40% when the dose was unchanged. 1, 2, 3
Over-reacting to an isolated low INR causes "dose chasing" and greater INR instability, which can paradoxically worsen anticoagulation control. 1
A recent study of 45,351 slightly out-of-range INRs found that watchful waiting resulted in 58.9% of follow-up INRs being in range versus 60.0% with dose changes—a statistically significant but clinically negligible difference that supports current guideline recommendations. 3
When to Consider Dose Adjustment
Only adjust the warfarin dose if a clear, identifiable cause for the low INR is present (e.g., missed doses, interacting medication, dietary vitamin K increase, or intercurrent illness). 1
If dose adjustment is warranted due to persistent subtherapeutic INR or a larger deviation:
- Adjust the total weekly warfarin dose by 5%–20% rather than altering the daily dose. 1, 4
- Practically, this can be achieved by increasing one or two daily doses by 1–2.5 mg. 1
- After any dose modification, re-measure INR 2–4 times per week until the therapeutic range is consistently achieved. 1, 5
Monitoring Schedule
- Recheck the INR in 1–2 weeks after deciding to maintain the current dose. 1, 5
- Once the INR stabilizes within the therapeutic range, gradually extend monitoring intervals to every 4–12 weeks. 1, 5
- Increase monitoring frequency whenever there are medication adjustments, dietary variations, intercurrent illness, or any bleeding event. 1, 5
Perioperative Context
If this INR of 1.5 occurs in the perioperative setting (patient preparing for surgery):
- A procedure with low bleeding risk may proceed when INR <1.5, and a procedure with intermediate or high bleeding risk may proceed when INR <1.2. 6
- For patients requiring bridging therapy (high thromboembolic risk), LMWH should be started when INR falls below the therapeutic target (typically when INR <2.0), administered 36 hours after the last warfarin dose. 7, 6
- The last preoperative dose of LMWH should be given at half the total daily dose, no less than 24 hours before surgery. 7
Common Pitfalls to Avoid
- Do not reflexively increase the warfarin dose for a single INR of 1.5—this leads to INR instability and does not improve time in therapeutic range. 1, 2, 3
- Do not delay rechecking the INR beyond 2 weeks—this leaves the patient potentially underanticoagulated for too long. 1, 5
- Do not assume the patient is non-compliant without investigation—dietary changes, new medications, or intercurrent illness are common causes. 1, 5